Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 4

2(33.3%)

Phase 2

1(16.7%)

6Total

N/A(3)

Phase 4(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06432894Recruiting

Performance Evaluation of ANI in Patients Under General Anesthesia With Remimazolam

Role: lead

NCT06091410Phase 4Active Not Recruiting

Immunogenicity of Concomitant Administration of COVID-19 Vaccines With Influenza Vaccines

Role: lead

NCT05970887Phase 4Completed

Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza Vaccines

Role: lead

NCT05258708Unknown

COVID-19 Vaccine Reactogenicity and Immunogenicity

Role: collaborator

NCT03625050Phase 2Completed

Efficacy and Safety of Chuna Manual Treatment as an Adjunctive Therapy After Total Knee Arthroplasty: A Study Protocol for a Single-Center, Randomized, Assessor Blind, Parallel-Group Clinical Trial

Role: collaborator

NCT03109951Not ApplicableCompleted

Abnormal Blood Sugar Tests in Diabetic Patients During Colonoscopy Preparation

Role: lead

NCT04056585Not ApplicableUnknown

Intermittent Compression Maneuver of Upper Arm to Reduce Axillary Brachial Plexus Block Onset Time

Role: lead

NCT02858856Not ApplicableUnknown

Clinical Trial of Sipjeondaebo-tang on Fatigue of Breast Cancer Patients

Role: collaborator

All 8 trials loaded